SSI
Ss Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for Nasdaq Uplisting
时间：2024-12-12 02:57:46 市场： 美股 综合
Seraphim Space Investment Trust Plc - as at 30 September 2024, Cash Balance Was £24.9M
时间：2024-11-26 15:08:37 市场： 综合
Silver Spike Investment Corp. Completes Loan Portfolio Acquisition
时间：2024-10-01 20:00:09 市场： 美股 综合
Silver Spike Investment Corp. Announces Stockholder Approval of Loan Portfolio Acquisition
时间：2024-09-24 05:00:00 市场： 综合 美股
GSK's HPV Vaccine Misses Main Goal in Early-to-Mid Stage Study GSK (GSK) said Wednesday that the early-to-mid stage study of its experimental herpes simplex virus vaccine, GSK3943104, did not meet the primary efficacy objective.The company said it would not advance the vaccine to Phase 3 trials but would continue the Phase 2 study to monitor safety and collect follow-up data on recurrent genital herpes.It added that it is working closely with investigators to inform trial participants.Shares of the company fell nearly 1% in premarket activity.Price: 43.72, Change: -0.38, Percent Change: -0.86
时间：2024-09-11 18:41:10 市场： 美股 综合
Regeneron, Sanofi's Dupixent Drug Meets Main Goal in 2 Late-Stage Trials Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) said Wednesday that a confirmatory phase 3 study of Dupixent met primary and key secondary goals in treating patients with uncontrolled, biologic-naive chronic spontaneous urticaria receiving background therapy with antihistamines.The study showed that Dupixent added to standard-of-care reduced itch severity from baseline by 8.64-point versus a 6.10-point reduction with placebo.The company said the treatment also reduced urticaria activity severity by 15.86 points from baseline versus 11.21 points with placebo.The safety results were also generally consistent with the known safety profile of Dupixent in its approved dermatological indications, the company said.Separately, Dupixent's pivotal trial evaluating its efficacy and safety in treating adults with moderate-to-severe bullous pemphigoid met primary and all key secondary endpoints.The study showed that 20% of p
时间：2024-09-11 16:08:00 市场： 美股 综合